KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Equity Average (2016 - 2025)

Historic Equity Average for AbbVie (ABBV) over the last 13 years, with Q3 2025 value amounting to -$1.4 billion.

  • AbbVie's Equity Average fell 12156.38% to -$1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.4 billion, marking a year-over-year decrease of 12156.38%. This contributed to the annual value of $6.9 billion for FY2024, which is 5029.26% down from last year.
  • As of Q3 2025, AbbVie's Equity Average stood at -$1.4 billion, which was down 12156.38% from $662.0 million recorded in Q2 2025.
  • In the past 5 years, AbbVie's Equity Average registered a high of $16.7 billion during Q4 2022, and its lowest value of -$1.4 billion during Q3 2025.
  • Over the past 5 years, AbbVie's median Equity Average value was $13.1 billion (recorded in 2021), while the average stood at $10.5 billion.
  • Its Equity Average has fluctuated over the past 5 years, first soared by 27213.06% in 2021, then tumbled by 12156.38% in 2025.
  • AbbVie's Equity Average (Quarter) stood at $14.5 billion in 2021, then rose by 14.82% to $16.7 billion in 2022, then plummeted by 32.38% to $11.3 billion in 2023, then crashed by 58.12% to $4.7 billion in 2024, then plummeted by 129.46% to -$1.4 billion in 2025.
  • Its last three reported values are -$1.4 billion in Q3 2025, $662.0 million for Q2 2025, and $2.4 billion during Q1 2025.